This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 May;136(5):1832-5.

doi: 10.1053/j.gastro.2009.03.010. Epub 2009 Mar 25.

Sorafenib in advanced hepatocellular carcinoma: a further step toward personalized therapy of liver cancer

Massimo Colombo

PMID: 19324105
DOI: 10.1053/j.gastro.2009.03.010

Comment

Sorafenib in advanced hepatocellular carcinoma: a further step toward personalized therapy of liver cancer

Massimo Colombo. Gastroenterology. 2009 May.

. 2009 May;136(5):1832-5.

doi: 10.1053/j.gastro.2009.03.010. Epub 2009 Mar 25.

Author

Massimo Colombo

PMID: 19324105
DOI: 10.1053/j.gastro.2009.03.010

No abstract available

PubMed Disclaimer

Comment on

Sorafenib in advanced hepatocellular carcinoma.
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J; SHARP Investigators Study Group. Llovet JM, et al. N Engl J Med. 2008 Jul 24;359(4):378-90. doi: 10.1056/NEJMoa0708857. N Engl J Med. 2008. PMID: 18650514 Clinical Trial.

Similar articles

Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
Rimassa L, Santoro A. Rimassa L, et al. Expert Rev Anticancer Ther. 2009 Jun;9(6):739-45. doi: 10.1586/era.09.41. Expert Rev Anticancer Ther. 2009. PMID: 19496710
Systemic therapies in hepatocellular carcinoma.
Wörns MA, Weinmann A, Schuchmann M, Galle PR. Wörns MA, et al. Dig Dis. 2009;27(2):175-88. doi: 10.1159/000218351. Epub 2009 Jun 22. Dig Dis. 2009. PMID: 19546557 Review.
Sorafenib: new indication. For some patients with liver cancer.
[No authors listed] [No authors listed] Prescrire Int. 2009 Apr;18(100):59. Prescrire Int. 2009. PMID: 19585718
Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer.
Blumenschein GR Jr, Gatzemeier U, Fossella F, Stewart DJ, Cupit L, Cihon F, O'Leary J, Reck M. Blumenschein GR Jr, et al. J Clin Oncol. 2009 Sep 10;27(26):4274-80. doi: 10.1200/JCO.2009.22.0541. Epub 2009 Aug 3. J Clin Oncol. 2009. PMID: 19652055 Clinical Trial.
Pathogenesis of hepatocellular carcinoma and molecular therapies.
Mínguez B, Tovar V, Chiang D, Villanueva A, Llovet JM. Mínguez B, et al. Curr Opin Gastroenterol. 2009 May;25(3):186-94. doi: 10.1097/MOG.0b013e32832962a1. Curr Opin Gastroenterol. 2009. PMID: 19387255 Review.

See all similar articles

Cited by

Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma.
Li D, Zhang T, Guo Y, Bi C, Liu M, Wang G. Li D, et al. Cell Death Dis. 2024 Jul 12;15(7):498. doi: 10.1038/s41419-024-06888-z. Cell Death Dis. 2024. PMID: 38997297 Free PMC article. Review.
Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Impact of Early Response to 4 Weeks of Treatment.
Lin CC, Hung CF, Chen WT, Lin SM. Lin CC, et al. Liver Cancer. 2015 Dec;4(4):228-40. doi: 10.1159/000367737. Epub 2015 Oct 15. Liver Cancer. 2015. PMID: 26734578 Free PMC article.
Concomitant lung metastasis in patients with advanced hepatocellular carcinoma.
Yang T, Lu JH, Lin C, Shi S, Chen TH, Zhao RH, Wang Y, Wu MC. Yang T, et al. World J Gastroenterol. 2012 May 28;18(20):2533-9. doi: 10.3748/wjg.v18.i20.2533. World J Gastroenterol. 2012. PMID: 22654451 Free PMC article.
CC Chemokine Ligand-2: A Promising Target for Overcoming Anticancer Drug Resistance.
Shi Z, Tu J, Ying Y, Diao Y, Zhang P, Liao S, Xiong Z, Huang S. Shi Z, et al. Cancers (Basel). 2022 Aug 31;14(17):4251. doi: 10.3390/cancers14174251. Cancers (Basel). 2022. PMID: 36077785 Free PMC article. Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science